Amgen Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Amgen (AMGN) PT Lowered to $182 at RBC Capital
October 31, 2018 7:00 AM EDTRBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $182.00 (from $193.00) while maintaining a Sector Perform rating.
... MoreAmgen (AMGN) Tops Q3 EPS by 24c, FY Guidance Tops Views
October 30, 2018 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q3 EPS of $3.69, $0.24 better than the analyst estimate of $3.45. Revenue for the quarter came in at $5.9 billion versus the consensus estimate of $5.77 billion.
GUIDANCE:
Amgen sees FY2018 EPS of $14.00-$14.25, versus the consensus of $14.02. Amgen sees... More
